# Mechanistic Study of Ocrevus

> **NCT04459988** · — · COMPLETED · sponsor: **University of Michigan** · enrollment: 35 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Ocrelizumab

## Key facts

- **NCT ID:** NCT04459988
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2022-10-25
- **Final completion:** 2022-10-25
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2024-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04459988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04459988, "Mechanistic Study of Ocrevus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04459988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*